SPTLC1 and Charcot-Marie-Tooth disease: Acute to subacute development of neurological deficits has been reported in patients with CMT secondary to mutations in the GJB1, MPZ, SH3TC2, SPTLC1, and FIG4 genes (19, 23–29).